Kairos Pharma to Participate in The Microcap Conference in January 2025
-
Honda and Nissan expected to begin merger talks
-
'Draconian' Vietnam internet law heightens free speech fears
-
Israeli women mobilise against ultra-Orthodox military exemptions
-
Asian markets track Wall St rally as US inflation eases rate worries
-
Tens of thousands protest in Serbian capital over fatal train station accident
-
Trump vows to 'stop transgender lunacy' as a top priority
-
Daniels throws five TDs as Commanders down Eagles, Lions and Vikings win
-
'Who's next?': Misinformation and online threats after US CEO slaying
-
Only 12 trucks delivered food, water in North Gaza Governorate since October: Oxfam
-
Langers edge Tiger and son Charlie in PNC Championship playoff
-
Explosive batsman Jacobs gets New Zealand call-up for Sri Lanka series
-
Holders PSG edge through on penalties in French Cup
-
Slovak PM Fico on surprise visit to Kremlin to talk gas deliveries
-
Daniels throw five TDs as Commanders down Eagles
-
Atalanta fight back to take top spot in Serie A, Roma hit five
-
Mancini admits regrets over leaving Italy for Saudi Arabia
-
Run machine Ayub shines as Pakistan sweep South Africa
-
Slovak PM Fico on surprise visit to Kremlin
-
Gaza rescuers say Israeli strikes kill 35
-
'Incredible' Liverpool must stay focused: Slot
-
Maresca 'absolutely happy' as title-chasing Chelsea drop points in Everton draw
-
Salah happy wherever career ends after inspiring Liverpool rout
-
Three and easy as Dortmund move into Bundesliga top six
-
Liverpool hit Spurs for six, Man Utd embarrassed by Bournemouth
-
Netanyahu vows to act with 'force, determination' against Yemen's Huthis
-
Mbappe back from 'bottom' as Real Madrid down Sevilla
-
Ali hat-trick helps champions Ahly crush Belouizdad
-
France kept on tenterhooks over new government
-
Salah stars as rampant Liverpool hit Spurs for six
-
Syria's new leader says all weapons to come under 'state control'
-
'Sonic 3' zips to top of N.America box office
-
Rome's Trevi Fountain reopens to limited crowds
-
Mbappe strikes as Real Madrid down Sevilla
-
'Nervous' Man Utd humiliated by Bournemouth
-
Pope again condemns 'cruelty' of Israeli strikes on Gaza
-
Lonely this Christmas: Vendee skippers in low-key celebrations on high seas
-
Troubled Man Utd humiliated by Bournemouth
-
2 US pilots shot down over Red Sea in 'friendly fire' incident: military
-
Man Utd embarrassed by Bournemouth, Chelsea held at Everton
-
France awaits fourth government of the year
-
Germany pledges security inquest into Christmas market attack
-
Death toll in Brazil bus crash rises to 41
-
Joshua bout only fight left for beaten Fury says promoter Hearn
-
Odermatt stays hot to break Swiss World Cup wins record
-
Neville says Rashford's career at Man Utd nearing 'inevitable ending'
-
Syria's new leader vows not to negatively interfere in Lebanon
-
Germany pledges security inquest after Christmas market attack
-
Putin vows 'destruction' on Ukraine after Kazan drone attack
-
Understated Usyk seeks recognition among boxing legends
-
France awaits appointment of new government
NYSE - LSE
Kairos Pharma to Participate in The Microcap Conference in January 2025
Kairos Pharma, (NYSE American:KAPA) a clinical stage biotechnology company is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
Kairos Pharma's management team will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company's recent developments, growth strategy, and investment opportunities.
About The Microcap Conference 2025
The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from microcap companies. The event offers a platform for companies to showcase their value propositions through presentations, one-on-one meetings, and networking opportunities.
The 2025 event will feature:
Keynote Speakers: Renowned industry figures, including Jon Ledecky, Co-Owner of the New York Islanders, who will engage in a fireside chat with CNBC's Bob Pisani; plus Tom Gardner, CEO of Motley Fool, who will share insights on investing, market trends, and entrepreneurial success.
Expert Panels and Presentations: Financial commentators Ron Insana (CNBC) and Charlie Gasparino (FOX Business) will cover critical topics for the US equity markets, from capital formation to regulatory updates and market trends.
Entertainment Headliner: A special performance by Tom Papa, celebrated comedian and host of Netflix specials, ensuring a memorable evening for attendees.
Hosted by DealFlow Events, The Microcap Conference is renowned for its blend of high-quality content, engaging networking, and exceptional entertainment. For more information, visit https://themicrocapconference.com.
About Kairos Pharma Ltd.
Based in Los Angeles, California, Kairos Pharma Ltd. (NYSE American:KAPA) is at the forefront of oncology therapeutics, utilizing structural biology to overcome drug resistance and immune suppression in cancer. Our lead candidate, ENV105, is an antibody that targets CD105-a protein identified as a key driver of resistance to various cancer treatments. Elevation of CD105 in response to standard therapy results in resistance and disease relapse. ENV105 aims to reverse drug resistance by targeting CD105 and restore the effectiveness of standard therapies across multiple cancer types. Currently, ENV105 is in a Phase 2 clinical trial for castrate-resistant prostate cancer and a Phase 1 trial for lung cancer aimed at addressing significant unmet medical needs. For more information, visit kairospharma.com.
Contact:
CORE IR
Louie Toma
[email protected]
SOURCE: Kairos Pharma Ltd.
P.Costa--AMWN
